Institutions · Entity Annotation Prototype (beta)

1articles mentioning institutions

2institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: BD Biosciences ×

BD Biosciences

This institution is selected. Its supporting articles are shown below.

BD Biosciences1

Articles mentioning BD Biosciences

1 articles · page 1 of 1

First-in-human phase 1 dose-escalation study of W0180, an anti-VISTA monoclonal antibody, with and without pembrolizumab in patients with locally advanced or metastatic solid tumours

bmjonc · full text · 2026-02-17 · 2 matching annotations

75.4%

Eastern Cooperative Oncology Group MSD BD Biosciences ECOG Performance Status W0180 pembrolizumab

…y and unknown (n=1 each).CPS, combined positive score; ECOG PS, Eastern Cooperative Oncology Group performance status; PD-1, programmed cell death protein-1; PD-L…

Browse institutions

BD Biosciences

Articles mentioning BD Biosciences

First-in-human phase 1 dose-escalation study of W0180, an anti-VISTA monoclonal antibody, with and without pembrolizumab in patients with locally advanced or metastatic solid tumours